{
    "organizations": [],
    "uuid": "fd6162c59891265961d8a9cdeaa839b523dffdce",
    "author": "",
    "url": "https://www.reuters.com/article/brief-pieris-pharmaceuticals-and-seattle/brief-pieris-pharmaceuticals-and-seattle-genetics-announce-multi-program-immuno-oncology-collaboration-idUSFWN1PZ0W5",
    "ord_in_thread": 0,
    "title": "BRIEF-Pieris Pharmaceuticals And Seattle Genetics Announce Multi-Program Immuno-Oncology Collaboration",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 52 AM / Updated 8 minutes ago BRIEF-Pieris Pharmaceuticals And Seattle Genetics Announce Multi-Program Immuno-Oncology Collaboration Reuters Staff 1 Min Read \nFeb 9 (Reuters) - Pieris Pharmaceuticals Inc: \n* PIERIS PHARMACEUTICALS AND SEATTLE GENETICS ANNOUNCE MULTI-PROGRAM IMMUNO-ONCOLOGY COLLABORATION Source text for Eikon: Further company coverage:",
    "published": "2018-02-09T13:47:00.000+02:00",
    "crawled": "2018-02-09T14:04:39.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "pharmaceutical",
        "seattle",
        "genetics",
        "announce",
        "collaboration",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "pieris",
        "pharmaceutical",
        "inc",
        "pieris",
        "pharmaceutical",
        "seattle",
        "genetics",
        "announce",
        "collaboration",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}